InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by LEDERMAN SETH, Chairman & CEO. Insider active across 1 companies, notably Tonix Pharmaceuticals Holding Corp.. Cumulatively, 4 disclosures have been logged. Total volume traded: €68k. The latest transaction was disclosed on 29 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€32,73820,000 shares@ €1.63690.013% mcap48.5% of flow
Common Stock, $0.001 par value
SEC:0001387131-22-007441:0·
Ideal exit: 26 Mar 2023 (T+270)
€22,253100,000 shares@ €0.22250.0089% mcap33.0% of flow
Common Stock, $0.001 par value
SEC:0001387131-22-003991:0·
Ideal exit: 20 Dec 2022 (T+270)
€6,26412,000 shares@ €0.522100.0% of flow
Common Stock, $0.001 par value
SEC:0001387131-21-009696·
Ideal exit: 25 Jun 2022 (T+270)
€6,26412,000 shares@ €0.5220.0025% mcap9.3% of flow
Common Stock, $0.001 par value
SEC:0001387131-21-009696:0·
Ideal exit: 25 Jun 2022 (T+270)
4 of 4 declarations
About LEDERMAN SETH
Seth Lederman is the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. He leads the company by overseeing its operations and developing strategies for innovation in the biopharmaceutical sector. His leadership is crucial for Tonix's growth.
